| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.06 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |